Poster: COVID-19 highlighted the use of wastewater testing as a complementary method to monitor emerging outbreaks of infectious pathogens, including those harboring antimicrobial resistance (AMR) genes. Antibiotic resistant bacteria are identified as a primary public health concern that threatens to eliminate the effective use of antibiotics. As a strategy to complement population testing, wastewater samples can be evaluated to identify increases in the presence of AMR genes in communities. However, the use of molecular testing methods is challenging because many genetic mechanisms contribute to AMR, with the most common being β-Lactamases. To be an effective surveillance strategy, these tests must be designed to identify a broad range of targets associated with AMR, and the methods must be sensitive given the larger wastewater sampling volumes used for analysis. The data described here demonstrate methods for improved sample processing and a head-to-head comparison of commercially available real-time PCR-based assays to assess AMR burden in wastewater samples.
top of page
Related PostsSee All
medRxiv, May 2023 "Human norovirus (HuNoV) GII RNA in wastewater solids at 145 United States wastewater treatment plants: Comparison to positivity rates of clinical specimens and modeled estimates of
Quantifying Respiratory Viruses in Wastewater Using GT Molecular's Digital PCR Assays coupled with Ceres Nanosciences' Nanotrap® Particle Technology, the ThermoFisher MagMAX™ Microbiome Ultra Nuclei
Quantifying Respiratory Viruses in Wastewater Using GT Molecular’s Digital PCR Assays coupled with Ceres Nanosciences' Nanotrap® Workflow and QIAGEN AllPrep PowerViral™ DNA/RNA Extraction Kit on the
bottom of page